Unlock instant, AI-driven research and patent intelligence for your innovation.

Ligand-drug-conjugate comprising single molecular weight polysarcosine

A technology of molecular weight and conjugates, which is applied in the field of conjugation technology, ligand-drug-conjugate of single molecular weight polysarcosine, to achieve the effects of improving drug loading capacity, easy large-scale production, and excellent yield

Pending Publication Date: 2020-08-14
马布林克生物科学公司
View PDF11 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although acceptable dispersity is relatively well defined (Gaussian distribution of molecular weight with a polydispersity index >1), these polydisperse PSARs cannot be used for certain applications requiring the use of shorter polydispersities of consistent length (unique and specific molecular weight). Homopolymer compounds and therefore absolutely homogeneous fields of application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ligand-drug-conjugate comprising single molecular weight polysarcosine
  • Ligand-drug-conjugate comprising single molecular weight polysarcosine
  • Ligand-drug-conjugate comprising single molecular weight polysarcosine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0256] Embodiment 1: the synthesis of polysarcosine compound (synthetic method 1 on the resin)

[0257] The reaction scheme is as follows.

[0258]

[0259] 1.1) General method

[0260] On-resin synthesis was performed in empty SPE plastic tubes filled with 20 μm polyethylene frit (Sigma-Aldrich). Agitation was performed using a Titramax 101 horizontal shaker (Heidolph). All synthesis yields reported are based on an initial theoretical resin loading of 0.63 mmol / g (labelled range indicated by the manufacturer). All reactions were performed at room temperature unless otherwise stated.

[0261] 1.2) Resin loading

[0262] Typically, 500mg NovaGEL TM Rink Amide beads (0.63 mmol / g, Novabiochem) were swelled in 5 mL DMF for 15 minutes. The first monomer was added by reacting 10 equivalents of bromoacetic acid with 13 equivalents of diisopropylcarbodiimide (Sigma-Aldrich) in 5 mL of DMF for 60 minutes at room temperature, followed by extensive washing with DMF (5 times 5...

Embodiment 2

[0276] Embodiment 2: the synthesis of polysarcosine compound (synthetic method 2 on the resin)

[0277] The reaction scheme is as follows.

[0278]

[0279] 2.1) General method

[0280] On-resin synthesis was performed in empty SPE plastic tubes filled with 20 μm polyethylene frit (Sigma-Aldrich). Agitation was performed using a Titramax 101 horizontal shaker (Heidolph). All synthesis yields reported are based on an initial resin loading of 1.1 mmol / g (labelled range indicated by the manufacturer). All reactions were performed at room temperature unless otherwise stated.

[0281] 2.2) Synthesis of Fmoc-Sar-Sar-OH

[0282]

[0283] 2.2.1) Synthesis of Fmoc-Sar-Sar-OtBu

[0284] In a round bottom flask, Fmoc-Sar-OH (2000 mg / 6.42 mmol) and HATU (2443 mg / 6.42 mmol) were dissolved in 28 mL of anhydrous DMF. DIPEA (2491 mg / 19.27 mmol) was added, and the mixture was stirred at room temperature for 3 minutes. Then, tert-butyl sarcosine hydrochloride (1167 mg / 6.42 mmol) wa...

Embodiment 3

[0304] Example 3: Synthesis of polysarcosine compounds with one or several azido-functionalized orthogonal linkers (tree Lipid Synthesis Method 3)

[0305] The reaction scheme is as follows.

[0306]

[0307] 3.1) General method

[0308] On-resin synthesis was performed in empty SPE plastic tubes filled with 20 μm polyethylene frit (Sigma-Aldrich). Agitation was performed using a Titramax 101 horizontal shaker (Heidolph). All synthesis yields reported are based on an initial resin loading of 1.1 mmol / g (labelled range indicated by the manufacturer). All reactions were performed at room temperature unless otherwise stated. The starting material was obtained as described in Example 2 above.

[0309] 3.2) Step (1)

[0310] A 3 molar solution of 2-azidoethan-l-amine in DMF was added (1 mL per 100 mg resin), the vessel was shaken for 45 minutes, drained and washed with DMF (4x) and DCM (4x).

[0311] 3.3) Step (2)

[0312] To the resin was added commercially available...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Ligand-Drug-Conjugate (LDC) comprising a single molecular weight homopolymer, in particular a single molecular weight polysarcosine.

Description

technical field [0001] The present invention relates to monomolecular weight homopolymers, a process for their preparation and their use especially in conjugation techniques. [0002] The present invention also relates to ligand-drug-conjugates (LDCs) comprising single molecular weight homopolymers, in particular single molecular weight polysarcosine. Background technique [0003] Ligand-drug-conjugates (LDCs) consist of at least one Ligand unit as a polypeptide or protein covalently linked via a synthetic linker to at least one therapeutic, diagnostic or marker molecule (hereinafter referred to as drug or D). The synthetic linker may comprise one or several bivalent arms for linking the Ligand unit and the Drug unit, which may be selected from spacers, linkers and cleavable moieties. The linker can also bear any monovalent moiety that can improve the properties of the LDC, such as storage stability, plasma stability or pharmacokinetic properties. Proteins or polypeptides ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/62A61K47/68
CPCA61K47/62A61K47/6803A61K47/6855A61K47/6883A61K47/68037A61K47/68031
Inventor W·弗里塞尔
Owner 马布林克生物科学公司